Log in to search using one of your social media accounts:

 

Cold and Flu: Prevention, Symptoms and Treatments
In much of the Northern Hemisphere, December through February is prime time for colds, influenza (flu), and other respiratory illnesses. Don’t let a cold or the flu ruin your holidays! Learn how to protect yourself and your family with these tips from the Food & Drug Administration (FDA): Get vaccinated against flu Wash your hands often Limit exposure to infected people Keep stress in check Eat a balanced diet Get enough sleep Exercise Symptoms Most viral respiratory infections, like a cold, come and go within a few days, with no lasting effects. But some cause serious health problems. In addition, people who u...
Source: NN/LM Middle Atlantic Region Blog - December 11, 2017 Category: Databases & Libraries Authors: Hannah Sinemus Tags: Consumer Health Health Professionals K-12 Public Health Source Type: news

The Ratcheting Price of the Pneumococcal Vaccine: What Gives? The Ratcheting Price of the Pneumococcal Vaccine: What Gives?
The price for Pfizer ’ s Prevnar 13 has increased 5 to 6 percent each year since its 2010 approval by the Food and Drug Administration.Kaiser Health News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 4, 2017 Category: Consumer Health News Tags: Family Medicine/Primary Care News Source Type: news

Pneumonia: Treatment with vaccines instead of antibiotics
(University of Zurich) A properly functioning immune system is key to resolve bacterial pneumonia. Researchers from the University Children's Hospital Zurich and UZH working with an international team have now found that specific immune cells are crucial for recovery. The researchers' work paves the way for developing new vaccines, which would also counteract the emerging resistance to antibiotics. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 21, 2017 Category: International Medicine & Public Health Source Type: news

Why India ’s High Court Should Overturn Decision to Grant Vaccine Patent to Pfizer
The unmerited patent on Pfizer ’s lifesaving pneumonia vaccine would limit access to children worldwide. Language English (Source: MSF News)
Source: MSF News - November 20, 2017 Category: International Medicine & Public Health Authors: Kavita Menon Source Type: news

MSF: India's Decision to Give Pfizer Unmerited Patent on Lifesaving Pneumonia Vaccine Limits Access for Children Globally
Press releaseMSF: India's Decision to Give Pfizer Unmerited Patent on Lifesaving Pneumonia Vaccine Limits Access for Children GloballyNovember 20, 2017At High Court of Delhi hearing tomorrow, Doctors Without Borders will urge India to remain the “pharmacy of the developing world” and rethink decision that solidifies Pfizer monopoly on critical pneumonia vaccine (Source: MSF News)
Source: MSF News - November 20, 2017 Category: International Medicine & Public Health Authors: Brienne Prusak Source Type: news

MSF Continues Efforts to Reduce Pneumonia Vaccine Price so More Kids Can Be Protected
Doctors Without Borders/M édecins Sans Frontières (MSF) is challenging a recent Indian court decision to give U.S. pharmaceutical corporation Pfizer a patent it doesn't deserve on its pneumonia vaccine Prevnar13 (PCV13). This decision solidifies Pfizer's monopoly across the globe and prevents vaccine manufacturers in India from making and selling more affordable versions of PCV13 for people in India and other countries where the patent exists until 2026. (Source: MSF News)
Source: MSF News - November 17, 2017 Category: International Medicine & Public Health Authors: Brienne Prusak Source Type: news

Global Routine Vaccination Coverage, 2016
Global coverage with the third dose of diphtheria and tetanus toxoids and pertussis-containing vaccine, the third dose of polio vaccine, and first dose of measles. Among new or underused vaccines, global coverage increased during 2010-2016 for completed vaccine series against rotavirus (8% to 25%), Streptococcus pneumoniae (11% to 42%), rubella (35% to 47%), Haemophilus influenzae type B (42% to 70%) and hepatitis B vaccine (74% to 84%). containing vaccine coverage has remained unchanged at 84%-86% since 2010. (Source: PHPartners.org)
Source: PHPartners.org - November 16, 2017 Category: International Medicine & Public Health Source Type: news

Acute Otitis Media in Young Children Today Acute Otitis Media in Young Children Today
A recent epidemiologic study paints a picture of early childhood AOM in the pneumococcal vaccine era.Medscape Pediatrics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 15, 2017 Category: Consumer Health News Tags: Pediatrics Viewpoint Source Type: news

Africa:Pneumonia Claims 1 Million African Kids Yearly
[CAJ News] Dakar -CIVIL society organisations across Africa are advocating for governments to invest in immunisation and eradicate pneumonia. The disease kills nearly 1 million children in Africa per year. Organisations in some ten countries have met in Senegal where they called for more domestic financing to pneumonia vaccines, routine immunisation programmes and strengthening of health systems. The organisations that met under the auspices of the just-commemorated World Pneumonia Day are from Cameroon, Ghana, Guinea, Ivor (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - November 15, 2017 Category: African Health Source Type: news

Nigeria:Nigeria Progress Slow Against Diarrhoea, Pneumonia
[Daily Trust] Nigeria failed to meet targets for pneumonia and diarrhoea prevention and treatment, according to a progress report by the International Vaccine Access Centre (IVAC). (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - November 8, 2017 Category: African Health Source Type: news

Promising Pneumonia Vaccine Under Development
Animal tests showed an immune response to 72 of the 90 - plus known strains of S. pneumoniae (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - November 2, 2017 Category: Respiratory Medicine Tags: Family Medicine, Infections, Internal Medicine, Emergency Medicine, Pediatrics, Pulmonology, Journal, Source Type: news

Pfizer beats profit estimates, raises 2017 earnings forecast
(Reuters) - Pfizer Inc's quarterly profit beat market estimates, partly helped by higher-than-expected sales of its blockbuster pneumonia vaccine Prevnar, and the company also raised its full-year earnings forecast. (Source: Reuters: Health)
Source: Reuters: Health - October 31, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Pneumonia vaccine breakthrough: New jab could spell the end of DEADLY condition
PNEUMONIA is a deadly condition that still affects millions, but a new vaccine could help end the serious infection for good. (Source: Daily Express - Health)
Source: Daily Express - Health - October 24, 2017 Category: Consumer Health News Source Type: news

Vaccine promises to wipe out pneumonia and sepsis
Researchers from the University at Buffalo have developed a vaccine that only targets harmful pneumonia-causing bacteria, while preserving 'good bugs' in the gut, unlike existing jabs. (Source: the Mail online | Health)
Source: the Mail online | Health - October 23, 2017 Category: Consumer Health News Source Type: news

New pneumonia vaccine protects against dozens of additional forms
A new vaccine being developed at the University at Buffalo not only targets 72 forms of S. pneumoniae, but can anticipate future versions of the disease. (Source: Health News - UPI.com)
Source: Health News - UPI.com - October 20, 2017 Category: Consumer Health News Source Type: news

The end of pneumonia? New vaccine offers hope
(University at Buffalo) A new vaccine under development provoked an immune response to 72 forms of the bacteria that's responsible for pneumonia, sepsis and meningitis. That's up from the 23 forms of bacteria covered by current immunizations. The new vaccine, which represents the 'most comprehensive' coverage of pneumococcal disease to date, could greatly reduce the number of deaths from the disease. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - October 20, 2017 Category: Biology Source Type: news

Doctors Without Borders Challenges Pfizer's Unmerited Patent for Pneumonia Vaccine in Delhi High Court
Press releaseDoctors Without Borders Challenges Pfizer's Unmerited Patent for Pneumonia Vaccine in Delhi High CourtOctober 13, 2017NEW YORK/NEW DELHI, OCTOBER 13, 2017—The international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières(MSF) filed a petition before the High Court of Delhi today to overturn a patent granted to Pfizer pharmaceutical corporation on the pneumococcal conjugate vaccine (PCV). (Source: MSF News)
Source: MSF News - October 18, 2017 Category: International Medicine & Public Health Authors: Brienne Prusak Source Type: news

How MSF Brought Down the Price of the Pneumonia Vaccine
VideoHow MSF Brought Down the Price of the Pneumonia VaccineOctober 16, 2017 (Source: MSF News)
Source: MSF News - October 16, 2017 Category: International Medicine & Public Health Authors: Melissa Pracht Source Type: news

MSF drags govt to Delhi HC over Pfizer's pneumonia vaccine patent
The Indian patent office granted Pfizer a patent for its vaccine PCV13 (13-valent pneumococcal conjugate vaccine), sold here under the brand ‘Prevenar13’ for over 10 years. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 13, 2017 Category: Pharmaceuticals Source Type: news

The World Is Running Out of Much Needed New Antibiotics
Posters: Misuse of antibiotics and risks. Credit: WHOBy Baher KamalROME, Oct 4 2017 (IPS)The world is running out of new antibiotics to combat the growing threat of antimicrobial resistance, a new specialised report warns ahead of this year’s World Antibiotic Awareness Week, adding that most of the drugs currently in the clinical pipeline are modifications of existing classes of antibiotics and are only short-term solutions. The latest World Health Organization (WHO) report on this issue “Antibacterial agents in clinical development – an analysis of the antibacterial clinical development pipeline, includi...
Source: IPS Inter Press Service - Health - October 4, 2017 Category: International Medicine & Public Health Authors: Baher Kamal Tags: Featured Global Headlines Health Human Rights TerraViva United Nations Source Type: news

Adults With Asthma Not Getting Pneumonia Vaccine As Recommended
BOSTON (CBS) – At about this time, we start talking about flu shots but many adults are missing out on another key vaccine. The pneumonia vaccine is recommended for all adults with asthma, but a new study finds that only 42% of people ages 18 to 64 who have asthma getting it. Also known as the pneumococcal vaccine, it protects against a type of bacteria that commonly causes pneumonia. A version of the vaccine is given to kids in early childhood, older adults, and people with chronic illnesses, including asthma. So why aren’t more than half of adults with asthma getting the shot? Perhaps they have never heard o...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - September 28, 2017 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health Local News Syndicated Local Dr. Mallika Marshall Flu Shot pneumonia vaccine Source Type: news

Has measles really been 'eliminated' in the UK?
"Measles eliminated in the UK for the first time," reports The Telegraph. This and other stories in the media are based on a new World Health Organization (WHO) report confirming the UK is now one of 33 countries in Europe to have "eliminated" measles. "Elimination" is the official term used once a country has reduced the number of cases of a disease to a low enough level to stop it spreading through the general population for at least three years. It doesn't mean that measles has been wiped out or eradicated in the UK. In 2016 there were more than 500 cases in England and Wales. However, the ...
Source: NHS News Feed - September 28, 2017 Category: Consumer Health News Tags: Pregnancy/child Source Type: news

Pneumococcal Vaccine Not Reaching Majority of Adults with Asthma (FREE)
By Kelly Young Edited by Susan Sadoughi, MD, and Richard Saitz, MD, MPH, FACP, DFASAM Many adults with asthma still aren't receiving the pneumococcal vaccine as recommended … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - September 28, 2017 Category: Primary Care Source Type: news

Pneumococcal Vaccine for Only Half With Work - Related Asthma
54 percent of adults with work - related asthma, 35 percent with non - work - related asthma vaccinated (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - September 28, 2017 Category: Respiratory Medicine Tags: Family Medicine, Infections, Internal Medicine, Allergy, Nursing, Pathology, Pharmacy, Pulmonology, Journal, Source Type: news

Many With Work - Related Asthma Not Getting Key Vaccine
Recommended pneumococcal shot taken by little more than half, CDC report shows (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - September 27, 2017 Category: Respiratory Medicine Tags: Infections, Pulmonology, Asthma, Preventive Medicine, News, Source Type: news

Many with Work-Related Asthma Not Getting Key Vaccine
Recommended pneumococcal shot taken by little more than half, CDC report shows Source: HealthDay Related MedlinePlus Pages: Asthma, Immunization, Occupational Health (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - September 27, 2017 Category: Consumer Health News Source Type: news

Many With Work-Related Asthma Not Getting Key Vaccine
WEDNESDAY, Sept. 27, 2017 -- Only half of American adults with work-related asthma get the recommended vaccination against pneumococcal disease, a new study finds. Adults with asthma are at increased risk for pneumococcal disease, and the U.S.... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - September 27, 2017 Category: General Medicine Source Type: news

Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein] Suspension for Intramuscular Injection) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - September 25, 2017 Category: Drugs & Pharmacology Source Type: news

Should I Get the Pneumonia Vaccine Every Year?
Title: Should I Get the Pneumonia Vaccine Every Year?Category: Doctor's& Expert's views on SymptomsCreated: 9/15/2017 12:00:00 AMLast Editorial Review: 9/15/2017 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - September 15, 2017 Category: Respiratory Medicine Source Type: news

Immunization Update: Making It Happen
Multiple immunizations are recommended for older adults, as are annual flu vaccines. Specifically, these include two pneumonia vaccines: PPSV23, the 23-valent vaccine containing pneumococcal capsular polysaccharide, and pneumococcal conjugate vaccine (PCV13) that protects older adults against 13 types of pneumococcal bacteria. PPSV23 is estimated to be approximately 50% effective in preventing pneumonia, and this increases when PCV13 is added. Based on probabilistic modeling, use of PCV13 added to the current PPSV23 prevents an estimated 12,000 cases of community-acquired pneumonia over the lifetime of a single cohort of i...
Source: Caring for the Ages - August 30, 2017 Category: Health Management Authors: Barbara Resnick Tags: The Board Room Source Type: news

New Guidance Clarifies Use of Pneumococcal, Influenza Vaccines in Older Adults
If the federal government ’s Healthy People 2020 goals are met, at least 90% of patients and residents in post-acute and long-term care facilities will be immunized against influenza and pneumococcal infection. (Source: Caring for the Ages)
Source: Caring for the Ages - August 30, 2017 Category: Health Management Authors: Christine Kilgore Source Type: news

India Grants Pfizer Patent on Pneumonia Vaccine India Grants Pfizer Patent on Pneumonia Vaccine
India has granted Pfizer Inc a patent for its powerful pneumonia vaccine Prevenar 13, in a blow to some health groups that said this would put the treatment out of reach of thousands in poorer nations.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 23, 2017 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news

Indian Patent Office Delivers Major Blow to Affordable Pneumonia Vaccine Hopes
Press releaseIndian Patent Office Delivers Major Blow to Affordable Pneumonia Vaccine HopesAugust 22, 2017Hopes for improved access to an affordable pneumococcal conjugate vaccine (PCV) that protects both children and adults from pneumonia was dealt a major blow after the Indian patent office granted a patent to the U.S. pharmaceutical corporation Pfizer. (Source: MSF News)
Source: MSF News - August 22, 2017 Category: International Medicine & Public Health Authors: Brienne Prusak Source Type: news

India grants Pfizer patent on pneumonia vaccine in blow to aid group
MUMBAI (Reuters) - India has granted Pfizer Inc a patent for its powerful pneumonia vaccine Prevenar 13, in a blow to some health groups that said this would put the treatment out of reach of thousands in poorer nations. (Source: Reuters: Health)
Source: Reuters: Health - August 22, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

India grants Pfizer patent for blockbuster brand Prevenar 13
India has seven pneumonia related deaths per 1,000 live births, according to the 2016 Pneumonia and Diarrhea Progress Report. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 22, 2017 Category: Pharmaceuticals Source Type: news

Penicillin Resistance Before and After PCV13 Introduction Penicillin Resistance Before and After PCV13 Introduction
How has the introduction of 13-valent pneumococcal conjugate vaccine impacted the prevalence of penicillin resistance?Emerging Infectious Diseases (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 21, 2017 Category: Consumer Health News Tags: Infectious Diseases Journal Article Source Type: news

Decline in Kids' Ear Infections Linked to Pneumococcal Vaccine
The shots are effective in killing the main bacterial cause, but other germs are growing, researchers find Source: HealthDay Related MedlinePlus Pages: Childhood Immunization, Ear Infections, Pneumococcal Infections (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - August 7, 2017 Category: Consumer Health News Source Type: news

Decline in Kids' Ear Infections Linked to Pneumococcal Vaccine
MONDAY, Aug. 7, 2017 -- American kids'ear infections dropped threefold over 10 years, compared to the 1980s, largely due to pneumococcal vaccines that protect against one type of bacteria that causes them, a new study suggests. However, the study,... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 7, 2017 Category: General Medicine Source Type: news

Decline in Kids' Ear Infections Linked to Pneumococcal Vaccine
Title: Decline in Kids' Ear Infections Linked to Pneumococcal VaccineCategory: Health NewsCreated: 8/7/2017 12:00:00 AMLast Editorial Review: 8/7/2017 12:00:00 AM (Source: MedicineNet Kids Health General)
Source: MedicineNet Kids Health General - August 7, 2017 Category: Pediatrics Source Type: news

Infectious diseases warning: The three vaccinations YOU should have by your 70s
INFECTIOUS diseases are responsible for a significant number of hospital admissions and deaths in the elderly. For this reason, there are particular vaccines recommended for people 65 and over - pneumococcal vaccine, flu vaccine and shingles vaccine. (Source: Daily Express - Health)
Source: Daily Express - Health - August 4, 2017 Category: Consumer Health News Source Type: news

Pneumococcal Vaccination in Adults Aged 65 Years or Older Pneumococcal Vaccination in Adults Aged 65 Years or Older
Have the 2014 revisions in ACIP's recommendations for pneumococcal vaccination in adults 65 and older led to an increase in vaccination coverage?Morbidity & Mortality Weekly Report (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 2, 2017 Category: Consumer Health News Tags: Public Health & Prevention Journal Article Source Type: news

Pfizer revenue misses as demand falls for older drugs, Prevnar
(Reuters) - Pfizer Inc's quarterly revenue missed Wall Street estimates on Tuesday, hurt by falling demand for its blockbuster pneumonia vaccine Prevnar as well as older drugs. (Source: Reuters: Health)
Source: Reuters: Health - August 1, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Pfizer revenue misses on lower Prevnar, Enbrel sales
(Reuters) - Pfizer Inc reported quarterly revenue on Tuesday that missed Wall Street estimates, driven by lower demand for its rheumatoid arthritis treatment Enbrel and pneumonia vaccine Prevnar. (Source: Reuters: Health)
Source: Reuters: Health - August 1, 2017 Category: Consumer Health News Tags: healthNews Source Type: news